A bibliometric study of publication patterns in access to medicines research in developing countries

Southern Med Review

Volumn 3, Issue 1, 2010, Pages 2-6

  Ritz, Lindsay Sarah ^a,b   Adam, Taghreed ^b   Laing, Richard ^b  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Access to medicines; Bibliometrics; Drug utilization; Essential medicines

Indexed keywords

ARTICLE; BIBLIOMETRICS; DEVELOPING COUNTRY; DRUG UTILIZATION; ECONOMIC DEVELOPMENT; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; MEDICAL RESEARCH; POLICY; PUBLICATION; SOCIAL STATUS; TREND STUDY;

EID: 77952753632     PISSN: None     EISSN: 11742704     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. World Health Organization. Essential Medicines List (EML) 30 years of vital health care. Geneva: 2008. http://www.who.int/mediacentre/factsheets/ fs325/en/index.html (Accessed 22 June2009).
2. World Health Organization. WHO Medicines Strategy 2008-2013 [document on the Internet]. Geneva: 2008. http://www.who.int/medicines/areas/policy/ medstrategy-consultation/en/index.html (Accessed 22 June 2009).
3. Cameron A, et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009. 373: 240-249.
4. MDG Gap Task Force. Millennium development goal 8. Delivering on the global partnership for achieving millennium development goals. Geneva: 2008. http://www.who.int/medicines/mdg/MDG8EnglishWeb.pdf (Accessed 12 Aug. 2009).
5. World Health Organization. The rational use of drugs: report of the Conference of Experts, Nairobi. Geneva: 1987.
6. Harris E. Building scientific capacity in developing countries. EMBO Report 2004; 5(1): 7-11. (Pubitemid 38228518)
7. UN Millennium Project. Prescription for Healthy Development: Increasing Access to Medicines. Report of the Task Force on HIV/ AIDS, Malaria, TB, and Access to Essential Medicines, Work ing Group on Access to Essential Medicines. 2005. Sterling, VA: Earthscan.
8. Bennett S, et al. From Mexico to Mali: progress in health policy and systems research. Lancet 2008; 372(9649): 1571-1578.
9. Aaserud M, et al. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst Rev 2006, Issue 2. Art. No.: CD005979.
10. Austvoll-Dahlgren A, et al. Pharmaceutical policies: effects of cap and co-payment on rational drug use. Cochrane Database Syst Rev 2008, Issue 1. Art. No.: CD007017.
11. Sturm H, et al. Pharmaceutical policies: effects of financial incentives for prescribers. Cochrane Database Syst Rev 2007, Issue 3. Art. No.: CD006731.
12. Aaserud M, et al. Pharmaceutical policies: effects on rational drug use, an overview of 13 reviews (Protocol). Cochrane Database Syst Rev 2006, Issue 2. Art. No.: CD006731.
13. DfID, Access to Medicines Research Network On-line Consultation: Summary of Responses. London: 2008. http://www.dfid.gov.uk/Documents/consultations/ ATMRN-consultsummary.pdf (Accessed 23 June 2009).
14. World Bank. Country Groups. 2009. http://go.worldbank.org/D7SN0B8YU0 (Accessed 22 June 2009).
15. WHO. WHO - its people and offices. 2009. http://www.who.int/about/ structure/en/index.html (Accessed 22 June 2009).
16. Ritz L, et al. Access to medicines Publications in Developing Countries: A Bibliometric Study and its Implications for the Access to Medicines Research Network. [document forthcoming]